Limitations of the present study include the exclusive use of the 3xTg mouse model; the use of other AD mouse models could give improved insight, particularly into understanding if the effects of PR are mediated by its effects on Aβ, tau, or both. The gene discussed is MAPT; the disease is Alzheimer disease.